On or around 07/23/2019 (Ongoing date of last review)
Filing Date: June 21, 2019
According to the Complaint, Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company and the world’s largest generic drug manufacturer.
The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements denying that Teva “engaged in any conduct that would give rise to liability” in various antitrust proceedings and investigations that enveloped the company; in truth, and as Defendants failed to disclose to investors, (i) contrary to its public denials, Teva had in fact engaged in a vast, industry-wide price-fixing scheme and other collusive misconduct since at least 2012; (ii) Teva was not only a participant, but the company at the heart of the anticompetitive scheme; and (iii) several Teva employees had such deep involvement in the scheme that they would ultimately be named personally as defendants in a sweeping civil enforcement action filed by the AGs of virtually every state in the nation.
Company & Securities Information
Defendant: Teva Pharmaceutical Industries Ltd.
Industry: Biotechnology & Drugs
Ticker Symbol: TEVA
Company Market: New York SE
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Employees' Retirement System of the City of St. Petersburg, Florida, et al. v. Teva Pharmaceutical Industries Ltd., et al.
COURT: E.D. Pennsylvania
DOCKET #: 19-CV-02711
JUDGE: Hon. Cynthia M. Rufe
DATE FILED: 06/21/2019
CLASS PERIOD START: 08/04/2017
CLASS PERIOD END: 05/10/2019
PLAINTIFF FIRMS NAMED IN COMPLAINT:
Promisloff Law, P.C. 5 Great Valley Parkway, Suite 210, Promisloff Law, P.C., PA 19355 215.259.5156 215.600.2642 ·